GlassScriptPhysician profile
James N Hawkins
NPI 1558421875
$3,348.88
in general payments reported to CMS, 2019-2025
24 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $542 · 2021: $854 · 2022: $689 · 2023: $250 · 2024: $545 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $892 · Education: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $891.71 |
| Education | $144.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $651.95 | 2019-2024 | |
| Angiodynamics, INC. | $576.80 | 2019-2022 | |
| Medtronic, INC. | $494.19 | 2022-2024 | Abre, Venaseal |
| Tactile Systems Technology INC | $337.44 | 2021-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Astellas Pharma US INC | $281.15 | 2022-2024 | Veozah, Myrbetriq |
| Pfizer INC. | $233.17 | 2020-2024 | |
| Hologic Sales and Service, LLC | $113.78 | 2019-2023 | Myosure Tissue Removal Device, Acessa Provu System |
| Aspira Women'S Health INC | $102.86 | 2021-2022 | |
| Avion Pharmaceuticals | $96.57 | 2020-2022 | |
| Therapeuticsmd, INC. | $72.38 | 2020-2021 | |
| Organon LLC | $59.35 | 2021-2022 | |
| Allergan, INC. | $55.51 | 2019-2020 | |
| Agile Therapeutics, INC. | $50.77 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $49.72 | 2019 | |
| Mayne Pharma Commercial LLC | $26.85 | 2023-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $22.16 | 2020 | |
| Myovant Sciences INC. | $20.20 | 2021 | |
| Medtronic Vascular, INC. | $19.52 | 2019 | |
| Evofem Biosciences, INC. | $16.11 | 2022 | |
| Sumitomo Pharma America, INC. | $15.93 | 2023 | Myfembree |
| Dysis Medical, INC. | $15.60 | 2020 | |
| Exeltis, USA INC. | $13.51 | 2022 | |
| Lupin INC. | $12.07 | 2020 | |
| Minerva Surgical, INC | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hawkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.